By Editor
Hope has risen about hope for future treatment of blindness as scientists at Johns Hopkins University have uncovered a surprising role for a vitamin A derivative in the development of human vision, challenging a scientific explanation that has stood for about three decades and opening new possibilities for research into treatments for sight-threatening eye diseases.
The discovery reveals how retinoic acid, a molecule produced from vitamin A, works alongside thyroid hormones to shape the foveola, the tiny region at the centre of the retina responsible for the sharpest human vision.
The researchers found that certain cells initially designed to detect blue light during early fetal development appear to transform into cells sensitive to red and green light, creating the specialised arrangement required for clear central vision.
The findings, published in the Proceedings of the National Academy of Sciences, could reshape scientific understanding of how the human eye develops and provide fresh insights into conditions such as macular degeneration and other diseases that cause vision loss.
“This is a key step toward understanding the inner workings of the center of the retina, a critical part of the eye and the first to fail in people with macular degeneration,” said Robert J. Johnston Jr., an associate professor of biology at Johns Hopkins University, who led the study.
“By better understanding this region and developing organoids that mimic its function, we hope to one day grow and transplant these tissues to restore vision.”
To investigate how sharp human vision develops, Johnston and his colleagues used miniature human retinal tissues, known as organoids, grown in the laboratory.
The organoids reproduce important features of developing human retinal tissue, enabling scientists to observe developmental processes that would otherwise be difficult to study during pregnancy.
By monitoring the miniature retinas over several months, the team was able to track how specialised light-detecting cells develop and organise themselves.
Their investigation focused on the foveola, a small but highly specialised region at the centre of the retina, the light-sensitive layer at the back of the eye that converts incoming light into signals interpreted by the brain.
The foveola is essential for detailed central vision, allowing humans to read, recognise faces and distinguish fine details. Although it occupies only a tiny fraction of the retina, the researchers said it contributes to approximately 50 per cent of human visual perception.
A major part of the discovery centres on cone cells, which enable daytime vision and colour perception.
Humans have three types of cone cells, commonly described as blue, green and red cones, each sensitive to different wavelengths of light. The brain combines signals from these cells to produce the wide range of colours humans can perceive.
However, the distribution of these cells varies across the retina. While the foveola contains red and green cones, it lacks blue cones, a specialised arrangement that supports exceptionally sharp central vision.
For decades, scientists have struggled to explain how this unusual arrangement develops, partly because commonly studied animals, including mice and fish, do not have the same retinal organisation as humans.
The Johns Hopkins researchers discovered that the process involves two coordinated biological mechanisms.
Their observations showed that between the 10th and 12th weeks of fetal development, a small number of blue cones are initially present in the developing foveola. By the 14th week, however, these cells appear to have transformed into red and green cones.
The team identified retinoic acid, a derivative of vitamin A, as one of the key regulators of this process. Its breakdown in the developing retina helps limit the formation of blue cones in the central region.
Thyroid hormones, which are widely known for their role in regulating metabolism, also influence the development of the retina. In this case, the hormones appear to encourage the remaining blue cones to change into red and green cones.
The discovery provides a new explanation for how the human eye develops the specialised cellular arrangement needed for its sharpest vision.
Beyond improving understanding of fetal eye development, the findings could help scientists investigate ways of repairing damaged retinal tissue.
The researchers believe laboratory-grown retinal organoids could eventually provide a platform for developing replacement tissues and exploring potential treatments for diseases that damage the retina.
However, the findings represent an important step in understanding the biology of human vision rather than an immediately available treatment for blindness.
